Skip to Content
Global News Select

Air New Zealand Says Long-Haul Travel Won't Meaningfully Recover in Next Year

   By Stephen Wright 
 

WELLINGTON, New Zealand--Air New Zealand Ltd. said its losses over two financial years will reach about 900 million New Zealand dollars ($630 million) as the pandemic prevents a meaningful recovery in its international business in the next 12 months.

The airline on Friday also said it has delayed the start of deliveries of new Boeing 787 Dreamliner aircraft until its 2024 financial year.

Air New Zealand expects a loss before significant items and tax of NZ$450 million for its current financial year and a comparable loss in the subsequent financial year ending June 2022.

"The airline is not expecting any meaningful recovery in long-haul demand in the 2022 financial year notwithstanding the rollout of global vaccination programs and the potential for long-haul borders to begin reopening progressively in the second half of the financial year," it said.

 

Write to Stephen Wright at stephen.wright@wsj.com

 

(END) Dow Jones Newswires

June 17, 2021 17:30 ET (21:30 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.